Systemic detection of cisplatin-induced apoptosis by fluorescently-labeled poly-caspase inhibitor (FLIVO)
Kun YANG,Dalian DING,Yong FU,Yongqi LI,Haiyan JIANG,Salvi Richard
DOI: https://doi.org/10.3969/j.issn.1672-2922.2016.01.023
2016-01-01
Abstract:Cisplatin is a platinum-based chemotherapy drug widely used to treat a variety of malignant tumors. In ad-dition to its potent antitumor actions, cisplatin is highly toxic to multiple organs, such as the kidney, nervous system, liver,and inner ear. FLIVO is a lipophilic injectable fluorescent tracer that crosses the blood-brain barrier, enters the cytoplasm and fluoresces in cells with activated caspases undergoing apoptosis in various organs in the body. In the current study, ethacrynic acid (EA, 40 mg/kg, I.V.) was injected into chinchillas to eliminate the blood-labyrinth barrier by disrupting the epithelium on the cochlear lateral wall and enhance the influx of following intraperitoneal injection of cisplatin (Cis, 0.8 mg/kg, I.P.) into the cochlea. Experimental animals were terminated 6 hours and 18 hours after Cis/EA treatment respectively. To monitor apoptosis throughout the cochlea, brain and body, 100 μl FLIVO detective solutions were injected through the jugular vein for 60 minutes circulation prior to termination. At the end of the experiment, animals were perfused intracardial-ly with phosphate buffer for 5 minutes, followed by transcardially perfusion with 10%formalin in PBS. The cochlea, cochle-ar nucleus, auditory cortex, hippocampus, kidney, and liver were harvested and then immersed in the above mentioned fixa-tive for 6 hours. After fixation, the cochlear basilar membrane was micro-dissected out and mounted as surface preparations. Frozen sections were made of tissues from the cochlear nucleus, auditory cortex, hippocampus, kidney and liver. Under a confocal microscope, specimens from the above mentioned organs were examined for FLIVO labeled fluorescent apoptotic cells. FLIVO labeling was absent in these organs in normal control chinchillas. At 6 hours after Cis/EA injection, evident FLIVO labeling was only detected in cochlear outer hair cells and some kidney cells, but not in other organs. In contrast, massive apoptotic cells labeled with FLIVO fluorescence appeared among cochlear hair cells at 18 hours post-Cis/EA. Sur-prisingly, extensive apoptotic labeling was also seen in the ventral cochlear nucleus, but not in the dorsal cochlear nucleus 18 h after Cis/EA treatment. Remarkably, moderate apoptotic labeling appeared at more central loci such as the hippocam-pus and auditory cortex. In addition, massive apoptotic labeling also appeared in kidney and liver cells 18 hours post-Cis/EA injection. These results indicate that Cis/EA treatment not only results in massive apoptosis in the cochlea, but widespread neurotoxicity with heavy cell death in the ventral cochlear nucleus and moderate apoptosis in the hippocampus and auditory cortex, as well as in the kidney and liver, which are consistent to the ototoxicity, neurotoxicity, nephrotoxicity, and hepato-toxicity properties of cisplatin.